A Review on Metabolic Complications and Management after Radical Cystectomy and Orthotopic Neoblastectomy

Haonan DONG; Haifeng WANG; Yinglong HUANG; Hongjin SHI; Lan MAO; Yijie LIU; Jiansong WANG

doi:10.12259/j.issn.2095-610X.S20221229

Volume 43 Issue 12

Dec. 2022

Turn off MathJax

Article Contents

Article Navigation > Journal of Kunming Medical University > 2022 > 43(12): 159-163

Haonan DONG, Haifeng WANG, Yinglong HUANG, Hongjin SHI, Lan MAO, Yijie LIU, Jiansong WANG. A Review on Metabolic Complications and Management after Radical Cystectomy and Orthotopic Neoblastectomy[J]. Journal of Kunming Medical University, 2022, 43(12): 159-163. doi: 10.12259/j.issn.2095-610X.S20221229

Citation:

Haonan DONG, Haifeng WANG, Yinglong HUANG, Hongjin SHI, Lan MAO, Yijie LIU, Jiansong WANG. A Review on Metabolic Complications and Management after Radical Cystectomy and Orthotopic Neoblastectomy[J]. Journal of Kunming Medical University, 2022, 43(12): 159-163. doi: 10.12259/j.issn.2095-610X.S20221229

Citation:

Haonan DONG, Haifeng WANG, Yinglong HUANG, Hongjin SHI, Lan MAO, Yijie LIU, Jiansong WANG. A Review on Metabolic Complications and Management after Radical Cystectomy and Orthotopic Neoblastectomy[J]. Journal of Kunming Medical University, 2022, 43(12): 159-163. doi: 10.12259/j.issn.2095-610X.S20221229

PDF( 551 KB)

A Review on Metabolic Complications and Management after Radical Cystectomy and Orthotopic Neoblastectomy

doi: 10.12259/j.issn.2095-610X.S20221229

Dept. of Urology，The 2nd Affiliate Hospital of Kunming Medical University， Yunnan Institute of Urology，Kunming Yunnan 650101，China

Received Date: 2022-08-18
Available Online: 2022-12-06
Publish Date: 2022-12-25

Abstract

Abstract

Bladder cancer is one of the common malignant tumors of urinary system, which can be divided into two categoties, non-muscle-invasive bladder cancer and muscle-invasive bladder cancer. Radical cystectomy is the treatment of choice for muscle-invasive bladder cancer. At present, orthotopic neobasical bladder surgery has become the preferred method of urinary diversion after radical cystectomy. Due to the use of different intestinal segments during surgery, different metabolic complications may occur after surgery, which also become one of the reasons for reducing the quality of life of patients after surgery. This article reviews the main types and management progress of metabolic complications after orthotopic neobasical bladder surgery.
- Bladder cancer,
- Radical cystectomy,
- Orthotopic urinary diversion,
- Metabolic complications

FullText(HTML)

References(30)

References

[1]	Zheng R,Zhang S,Zeng H,et al. Cancer incidence and mortality in China,2016[J]. Journal of the National Cancer Center,2022,2(1):1-9. doi: 10.1016/j.jncc.2022.02.002
[2]	Witjes J A,Bruins H M,Cathomas R,et al. European association of urology guidelines on muscle-invasive and metastatic bladder cancer:Summary of the 2020 guidelines[J]. Eur Urol,2021,79(1):82-104. doi: 10.1016/j.eururo.2020.03.055
[3]	Joensen U N,Maibom S L,Poulsen A M. Surgical management of muscle invasive bladder cancer:A review of current recommendations[J]. Semin Oncol Nurs,2021,37(1):151104.
[4]	Li K,Lin T,Chinese Bladder Cancer C,et al. Current status of diagnosis and treatment of bladder cancer in China - Analyses of Chinese bladder cancer consortium database[J]. Asian J Urol,2015,2(2):63-69. doi: 10.1016/j.ajur.2015.04.016
[5]	McDougal W S. Metabolic complications of urinary intestinal diversion[J]. Journal of Urology,1992,147(5):1199-1208. doi: 10.1016/S0022-5347(17)37517-1
[6]	Stein R,Rubenwolf P. Metabolic consequences after urinary diversion[J]. Front Pediatr,2014,2:15.
[7]	Mills R D,Studer U E. Metabolic consequences of continent urinary diversion[J]. The Journal of Urology,1999,161(4):1057-1066. doi: 10.1016/S0022-5347(01)61590-8
[8]	Shamsa A. Gastric pouch after simple or radical cystectomy for benign and malignant bladder disease[J]. Nephrourol Mon,2014,6(6):e17890.
[9]	De Toledo A F,da Cunha C E B,Steppe C H,et al. Gastric neobladders:Surgical outcomes of 91 cases using different techniques[J]. Int Braz J Urol,2018,44(5):914-919.
[10]	Koraitim M M,Khalil M R,Ali G A,et al. Micturition after gastrocystoplasty and gastric bladder replacement[J]. The Journal of Urology,1999,161(5):1480-1485. doi: 10.1016/S0022-5347(05)68931-8
[11]	Lin D W,Santucci R A,Mayo M E,et al. Urodynamic evaluation and long-term results of the orthotopic gastric neobladder in men[J]. The Journal of Urology,2000,164(2):356-359.
[12]	Dahl D M, McDougal W S. Use of intestinal segments in urinary diversion[M]. In: Wein AJ. Campbell-Walsh Urology. Philadelphia: Saunders Elsevier, 2007, 2534–2578.
[13]	Hautmann R E,Botto H,Studer U E. How to obtain good results with orthotopic bladder substitution:The 10 commandments[J]. European Urology Supplements,2009,8(9):712-717.
[14]	Muller G,Butea-Bocu M,Brock O,et al. Association between development of metabolic acidosis and improvement of urinary continence after ileal neobladder creation[J]. J Urol,2020,203(3):585-590.
[15]	Kim K H,Yoon H S,Yoon H,et al. Risk factors for developing metabolic acidosis after radical cystectomy and ileal neobladder[J]. PLoS One,2016,11(7):e0158220.
[16]	Qu L G,Lawrentschuk N. Orthotopic neobladder reconstruction:Patient selection and perspectives[J]. Res Rep Urol,2019,11:333-341.
[17]	Herdiman O,Ong K,Johnson L,et al. Orthotopic bladder substitution (neobladder):Part II:Postoperative complications,management,and long-term follow-up[J]. J Wound Ostomy Continence Nurs,2013,40(2):171-180.
[18]	Stein R,Wiesner C,Beetz R,et al. Urinary diversion in children and adolescents with neurogenic bladder:The mainz experience. part II:Continent cutaneous diversion using the Mainz pouch I[J]. Pediatr Nephrol,2005,20(7):926-931. doi: 10.1007/s00467-005-1848-2
[19]	Chang S S,Bochner B H,Chou R,et al. Treatment of non-metastatic muscle-invasive bladder cancer:AUA/ASCO/ASTRO/SUO guideline[J]. J Urol,2017,198(3):552-559. doi: 10.1016/j.juro.2017.04.086
[20]	Bilge M,Adas M,Yesilova A,et al. Osteomalacia as a result of urinary diversion[J]. Acta Endocrinol (Buchar),2017,13(4):491-493. doi: 10.4183/aeb.2017.491
[21]	Richard P O,Bashir S,Riverin B D,et al. Risk of bone fractures following urinary intestinal diversion:A population based study[J]. J Urol,2019,202(2):319-325.
[22]	Hirukawa M,Funakoshi H,Tsukamoto T,et al. Osteomalacia due to a bladder reconstruction performed 35 years previously[J]. Intern Med,2012,51(15):2051-2055. doi: 10.2169/internalmedicine.51.7980
[23]	Cano Megias M,Munoz Delgado E G. Bone and metabolic complications of urinary diversions[J]. Endocrinol Nutr,2015,62(2):100-105.
[24]	Hautmann R . Urinary diversion. World Health Organization (WHO) consensus conference on bladder cancer[J]. Urology,2007,69(1 Suppl):17-49.
[25]	Boucher,Michelle (NURSE),Bryan,et al. Deficiency or dementia? Exploring b12 deficiency after urostomy.[J]. British Journal of Nursing,2015,24(11):594-597. doi: 10.12968/bjon.2015.24.11.594
[26]	Van der Aa F,Joniau S,Van Den Branden M,et al. Metabolic changes after urinary diversion[J]. Adv Urol,2011,2011:764325.
[27]	Reddy M,Kader K. Follow-up management of cystectomy patients[J]. Urol Clin North Am,2018,45(2):241-247. doi: 10.1016/j.ucl.2018.01.001
[28]	Sagalowsky A I,Frenkel E P. Cobalamin profiles in patients after urinary diversion[J]. Journal of Urology,2002,167(4):1696-1700. doi: 10.1016/S0022-5347(05)65180-4
[29]	Sperling C D,Lee D J,Aggarwal S. Urinary diversion:core curriculum 2021[J]. Am J Kidney Dis,2021,78(2):293-304. doi: 10.1053/j.ajkd.2020.12.023
[30]	Roth S,Semjonow A,Waldner M,et al. Risk of bowel dysfunction with diarrhea after continent urinary diversion with ileal and ileocecal segments[J]. Journal of Urology,1995,154(5):1696-1699. doi: 10.1016/S0022-5347(01)66754-5

Relative Articles(20)

Relative Articles

[1]	Yuqin LIU, Mingying YANG, Liufang WANG, Siya XIA, Danna LI, Xijuan ZHAO, Ya WANG. Development of a Patient-reported Outcome Scale For Bladder Cancer and Test of Reliability and Validity. Journal of Kunming Medical University, 2024, 45(7): 183-190. doi: 10.12259/j.issn.2095-610X.S20240727
[2]	Yijun AN, Lidan YU, Meisu ZHAO, Dongmei MA, Chunhua YANG, Yao KONG. The Application of Prognostic Model of Lysosomal Related Genes in Bladder Cancer. Journal of Kunming Medical University, 2024, 45(5): 66-72. doi: 10.12259/j.issn.2095-610X.S20240510
[3]	Sheng LIU, Fei YUAN, Hongqing ZHOU, Mingsheng LIU, Donghuan ZOU, Yu LI, Zihan DAI, Guanyu CHEN, Feng GUO. Analysis of the Efficacy of Complete Pelvic Floor Peritoneal Reconstruction Technique in Total Cystectomy with Orthotopic Neobladder. Journal of Kunming Medical University, 2024, 46(): 1-7.
[4]	Yuqing XIE, Jun WANG, Xuebi JI, Ping WANG, Haifeng WANG, Xumin LI, Linya HUANG. Research Progress on Risk Factors and Risk Assessment of Urinary Tract Infection in Patients with Ureterostomy. Journal of Kunming Medical University, 2023, 44(11): 158-163. doi: 10.12259/j.issn.2095-610X.S20231124
[5]	Jun XIE, Shaoyou LIU, Hongjin SHI, Qiuyu MAO, Hong YANG. Enhanceing Effect of EZH2 Inhibitors in Combination with GC Chemotherapeutic Agents in Bladder Cancer. Journal of Kunming Medical University, 2023, 44(10): 67-76. doi: 10.12259/j.issn.2095-610X.S20231017
[6]	Shi CHEN, Shi FU, Zhiyong TAN, Jiansong WANG, Haifeng WANG. Research Progress of Autophagy in the Development and Treatment of Bladder Cancer. Journal of Kunming Medical University, 2023, 44(5): 168-174. doi: 10.12259/j.issn.2095-610X.S20230503
[7]	Jun GU, Zexi HE, Ting LUAN, Haifeng WANG, Jiansong WANG, Mingxia DING. Research Progress of Exosomes-derived Long Non-coding RNA in Bladder Cancer. Journal of Kunming Medical University, 2022, 43(1): 150-156. doi: 10.12259/j.issn.2095-610X.S20220110
[8]	Zhi YAN, Jingang HAO, Yunyun SHANG. Value of VI-RADS Scoring System in Precision Treatment of Bladder Cancer. Journal of Kunming Medical University, 2022, 43(3): 74-79. doi: 10.12259/j.issn.2095-610X.S20220322
[9]	Li Dan Na , Wang Jun , Yang Ming Ying , Yu Li Rui , Li Na , Yang Yi Jiao . . Journal of Kunming Medical University, 2020, 41(09): 67-71.
[10]	Huang Yu , Luan Ting , Wang Hai Feng , Wang Jian Song . . Journal of Kunming Medical University, 2019, 40(11): 147-151.
[11]	Yang Can , Gong Yu Hang , Wang Hai Feng , Li Hai Hao , Liu Jing Yu , Wang Wei , Wang Jian Song , Zuo Yi Gang , Chen Jian , Zhan Hui , Ding Ming Xia . The Research of Monoclonal Antibody KMP1 Inhibited Bladder Cancer EJ Cell Lines Growth and Metastasis in Vivo. Journal of Kunming Medical University, 2018, 39(05): 1-6.
[12]	Li Dan Na , Yang Ming Ying , Wang Jun , Wang Liu Fang , Wu Guang Liu , Wang Hui Xiao , Chen Jiang Guo , Yao Cheng , Huang Ying Long . . Journal of Kunming Medical University, 2018, 39(09): 27-32.
[13]	Lei Yu Ying , Gao Jie , Wang Rao Xiang , Chuan Li Xue , Hao Jin Gang . Value of Diffusion Weighted Imaging in the Diagnosis of Bladder Cancer. Journal of Kunming Medical University, 2017, 38(07): 136-139.
[14]	Huang Zhen Hua , Shi Xin , Wang Hui Tao , Zhang Jing Song , Wang Guang , Hao Jin Gang , Liu Jian He . Application Value of DWI in Diagnosis of T Staging of Bladder Cancer. Journal of Kunming Medical University, 2016, 37(12): 67-71.
[15]	Hu Xin Yi . Radical Cystectomy and Orthotopic Urinary Diversion with 3D Laparoscopy. Journal of Kunming Medical University,
[16]	Zhang Jing Song . . Journal of Kunming Medical University,
[17]	Ma Zhen . . Journal of Kunming Medical University, 2012, 33(07): 1-1.
[18]	. . Journal of Kunming Medical University,
[19]	. . Journal of Kunming Medical University,
[20]	Yang Ming Ying . . Journal of Kunming Medical University,